| Periode | Prosjekttittel | Prosjektleder |
|---|---|---|
| 2005 - 2007 | Novel therapeutic strategies for stimulation of anti-neoplastic immune activityNovel therapeutic strategies for stimulation of anti-neoplastic immune activity | Kjetil Taskén |
| 2005 - 2009 | MOLECULAR AND BIOLOGICAL STUDIES OF CANCER METASTASISMOLECULAR AND BIOLOGICAL STUDIES OF CANCER METASTASIS | Øystein Fodstad |
| 2005 - 2008 | Vaccination against B cell cancers: from experimental immunology to patientsVaccination against B cell cancers: from experimental immunology to patients | Bjarne Bogen |
| 2005 - 2007 | GENOME MAINTENANCE MECHANISMS AND THEIR ROLE IN PREVENTING CANCER DEVELOPMENTGENOME MAINTENANCE MECHANISMS AND THEIR ROLE IN PREVENTING CANCER DEVELOPMENT | Hans Einar Krokan |
| 2004 - 2007 | Retinoids, antioxidants and cancerRetinoids, antioxidants and cancer | Rune Blomhoff |
| 2004 - 2008 | The Norwegian Women and Cancer post genome cohort study - NOWACThe Norwegian Women and Cancer post genome cohort study - NOWAC | Eiliv Lund |
| 2004 - 2009 | Genetic predictors of mammographic densityGenetic predictors of mammographic density | Giske Ursin |
| 2004 - 2009 | Critical regulatory networks for tumor-vascular interactions and activated angiogenesis in urogenital cancersCritical regulatory networks for tumor-vascular interactions and activated angiogenesis in urogenital cancers | Lars Andreas Akslen |
| 2004 - 2009 | Developmental biology of solid tumours may pave the way for advanced medicineDevelopmental biology of solid tumours may pave the way for advanced medicine | Ragnhild A. Lothe |
| 2004 - 2008 | Early life factors and adult cancer riskEarly life factors and adult cancer risk | Lars J. Vatten |
| 2004 - 2008 | Molecular mechanisms of androgen action and prostate carcinogenesisMolecular mechanisms of androgen action and prostate carcinogenesis | Fahri Saatcioglu |
| 2004 - 2004 | Molecular mechanisms of androgen action and prostate carcinogenesisMolecular mechanisms of androgen action and prostate carcinogenesis | Fahri Saatcioglu |
| 2004 - 2004 | Opioids, Symptom Management and Palliation Research GroupOpioids, Symptom Management and Palliation Research Group | Stein Kaasa |
| 2004 - 2009 | Opioids, Symptom Management and Palliation Research GroupOpioids, Symptom Management and Palliation Research Group | Stein Kaasa |
| 2001 - 2004 | Nutrients, gene regulation and cancerNutrients, gene regulation and cancer | Rune Blomhoff |
| 2001 - 2004 | The "Norwegian Women and Cancer Study" - a representative population based prospective studyThe "Norwegian Women and Cancer Study" - a representative population based prospective study | Eiliv Lund |
| 2001 - 2005 | Integration of clinical and basic research to improve treatment of multiple myelomaIntegration of clinical and basic research to improve treatment of multiple myeloma | Anders Waage |
| 2001 - 2005 | Biological, diagnostic and therapeutic aspects of cancer metastasisBiological, diagnostic and therapeutic aspects of cancer metastasis | Øystein Fodstad |
| 2000 - 2005 | Molecular mechanisms of androgen action in prostate cancerMolecular mechanisms of androgen action in prostate cancer | Fahri Saatcioglu |
| 2000 - 2005 | Perinatal and Adolescent Risk Factors for Breast CancerPerinatal and Adolescent Risk Factors for Breast Cancer | Lars J. Vatten |
| 2000 - 2004 | Intergrated basic and clinical research on pain treatment in cancerIntergrated basic and clinical research on pain treatment in cancer | Stein Kaasa |
| 2000 - 2003 | Tumour suppressor genes on chromosome 16q (SRO2 og SRO3). A study in breast cancer patientsTumour suppressor genes on chromosome 16q (SRO2 og SRO3). A study in breast cancer patients | Hans Prydz |
Norges forskningsråd
Postboks 2700 St. Hanshaugen 0131 Oslo
Besøksadresse: Stensberggata 26
Telefon: 22 03 70 00
Telefaks: 22 03 70 01
E-post:
post@forskningsradet.no
Henvendelser om nettsidene:
webmaster@forskningsradet.no